바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Next
e-Submission

Vol.72 No.1
Citation Share

Contributors of the Severity of Airflow Limitation in COPD Patients

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2012, v.72 no.1, pp.8-14
Yoonki Hong (University of Ulsan College of Medicine)



Ji-Hyun Lee (CHA University College of Medicine)

Young Kyung Lee (Kyunghee University School of Medicine)



Sang-Min Lee (Seoul National University College of Medicine)


Tae Rim Shin (Sungkyunkwan University School of Medicine)



Jae Seung Lee (University of Ulsan College of Medicine)


Yoonki, H. , Ji-Hyun, L. , Young, K. L. , Sang-Min, L. , Tae, R. S. , Jae, S. L. , & (2012). Contributors of the Severity of Airflow Limitation in COPD Patients. Tuberculosis & Respiratory Diseases, 72(1), 8-14.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background: Although airway obstruction in chronic obstructive pulmonary disease (COPD) is due to pathologic processes in both the airways and the lung parenchyma, the contribution of these processes, as well as other factors, have not yet been evaluated quantitatively. We therefore quantitatively evaluated the factors contributing to airflow limitation in patients with COPD. Methods: The 213 COPD patients were aged ＞45 years, had smoked ＞10 pack-years of cigarettes, and had a post-bronchodilator forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) ＜0.7. All patients were evaluated by medical interviews, physical examination, spirometry, bronchodilator reversibility tests, lung volume, and 6-minute walk tests. In addition, volumetric computed tomography (CT) was performed to evaluate airway wall thickness, emphysema severity, and mean lung density ratio at full expiration and inspiration. Multiple linear regression analysis was performed to identify the variables independently associated with FEV1 - the index of the severity of airflow limitation. Results: Multiple linear regression analysis showed that CT measurements of mean lung density ratio (standardized coefficient β=−0.46; p＜0.001), emphysema severity (volume fraction of the lung less than −950 HU at full inspiration; β=−0.24; p＜0.001), and airway wall thickness (mean wall area %; β=−0.19, p=0.001), as well as current smoking status (β=−0.14; p=0.009) were independent contributors to FEV1. Conclusion: Mean lung density ratio, emphysema severity, and airway wall thickness evaluated by volumetric CT and smoking status could independently contribute to the severity of airflow limitation in patients with COPD.

keywords
Pulmonary Disease, Chronic Obstructive, Forced Expiratory Volumes, Tomography, X-Ray Computed

Reference

1.

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55.

2.

2. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364:709-21.

3.

3. Celli BR. Roger S. Mitchell lecture. Chronic obstructive pulmonary disease phenotypes and their clinical relevance. Proc Am Thorac Soc 2006;3:461-5.

4.

4. Cerveri I, Dore R, Corsico A, Zoia MC, Pellegrino R, Brusasco V, et al. Assessment of emphysema in COPD: a functional and radiologic study. Chest 2004;125: 1714-8.

5.

5. Reilly J. Using computed tomographic scanning to advance understanding of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3:450-5.

6.

6. Nakano Y, Wong JC, de Jong PA, Buzatu L, Nagao T, Coxson HO, et al. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med 2005;171:142-6.

7.

7. Hasegawa M, Nasuhara Y, Onodera Y, Makita H, Nagai K, Fuke S, et al. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:1309-15.

8.

8. Lee YK, Oh YM, Lee JH, Kim EK, Lee JH, Kim N, et al. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung 2008;186:157-65.

9.

9. Kim WJ, Oh YM, Sung J, Kim TH, Huh JW, Jung H, et al. Lung function response to 12-week treatment with combined inhalation of long-acting beta2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease. Lung 2008;186:381-6.

10.

10. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26:720-35.

11.

11. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38.

12.

12. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005;26:511-22.

13.

13. Wood SA, Zerhouni EA, Hoford JD, Hoffman EA, Mitzner W. Measurement of three-dimensional lung tree structures by using computed tomography. J Appl Physiol 1995;79:1687-97.

14.

14. Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000;162:1102-8.

15.

15. Orlandi I, Moroni C, Camiciottoli G, Bartolucci M, Belli G, Villari N, et al. Spirometric-gated computed tomography quantitative evaluation of lung emphysema in chronic obstructive pulmonary disease: a comparison of 3 techniques. J Comput Assist Tomogr 2004;28: 437-42.

16.

16. Washko GR, Criner GJ, Mohsenifar Z, Sciurba FC, Sharafkhaneh A, Make BJ, et al. Computed tomographic- based quantification of emphysema and correlation to pulmonary function and mechanics. COPD 2008;5:177-86.

17.

17. Bakhtavar K, Sedighi N, Moradi Z. Inspiratory and expiratory high-resolution computed tomography (HRCT) in patients with chemical warfare agents exposure. Inhal Toxicol 2008;20:507-11.

18.

18. Lucidarme O, Grenier PA, Cadi M, Mourey-Gerosa I, Benali K, Cluzel P. Evaluation of air trapping at CT: comparison of continuous-versus suspended-expiration CT techniques. Radiology 2000;216:768-72.

19.

19. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-53.

20.

20. Gevenois PA, De Vuyst P, Sy M, Scillia P, Chaminade L, de Maertelaer V, et al. Pulmonary emphysema: quantitative CT during expiration. Radiology 1996;199: 825-9.

21.

21. Omori H, Nakashima R, Otsuka N, Mishima Y, Tomiguchi S, Narimatsu A, et al. Emphysema detected by lung cancer screening with low-dose spiral CT: prevalence, and correlation with smoking habits and pulmonary function in Japanese male subjects. Respirology 2006;11:205-10.

22.

22. Orlandi I, Moroni C, Camiciottoli G, Bartolucci M, Pistolesi M, Villari N, et al. Chronic obstructive pulmonary disease: thin-section CT measurement of airway wall thickness and lung attenuation. Radiology 2005; 234:604-10.

23.

23. Berger P, Perot V, Desbarats P, Tunon-de-Lara JM, Marthan R, Laurent F. Airway wall thickness in cigarette smokers: quantitative thin-section CT assessment. Radiology 2005;235:1055-64.

24.

24. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Golobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. [place unknown]: GOLD; 2009.

25.

25. Dransfield MT, Washko GR, Foreman MG, Estepar RS, Reilly J, Bailey WC. Gender differences in the severity of CT emphysema in COPD. Chest 2007;132:464-70.

26.

26. Martinez FJ, Curtis JL, Sciurba F, Mumford J, Giardino ND, Weinmann G, et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007; 176:243-52.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy